Pharmacological modulation of nitric oxide synthesis by mechanism-based inactivators and related inhibitors

Pharmacology and Therapeutics

Volumn 84, Issue 2, 1999, Pages 157-178

  Bryk, Ruslana ^a   Wolff, Donald J ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Intact cells; Kinetics; Mechanism based inactivator; Nitric oxide; Nitric oxide synthase

Indexed keywords

AMINO ACID DERIVATIVE; AMINOGUANIDINE; ARGININE DERIVATIVE; LYSINE DERIVATIVE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME KINETICS; ENZYME STRUCTURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ENZYME INHIBITORS; HUMANS; ISOENZYMES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0032877782     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(99)00030-3     Document Type: Review

References (172)

1. Abu-Soud H.M., Stuehr D.J. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc Natl Acad Sci USA. 90:1993;10769-10772.
2. Abu-Soud H.M., Yoho L.L., Stuehr D.J. Calmodulin controls neuronal nitric-oxide synthase by a dual mechanism. J Biol Chem. 269:1994;32047-32050.
3. W-hydroxyarginine to nitric oxide and citrulline Biochemistry. 36:1997;10811-10816.
4. Albakri Q.A., Stuehr D.J. Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability. J Biol Chem. 271:1996;5414-5421.
5. 5-(1-imino-3-butenyl)-L-ornithine. J Biol Chem. 273:1998;8882-8889.
6. Baek K.J., Thiel B.A., Lucas S., Stuehr D.J. Macrophage nitric oxide synthase subunits. J Biol Chem. 268:1993;21120-21129.
7. Barnes P.J. Nitric oxide and airway disease. Ann Med. 27:1995;389-393.
8. Bec N., Gorren A.C.F., Voelker C., Mayer B., Lange R. Reaction of neuronal nitric-oxide synthase with oxygen at low temperature. J Biol Chem. 273:1998;13502-13508.
9. Bogle R.G., Baydoun A.R., Pearson J.D., Moncada S., Mann G.E. L-Arginine transport is increased in macrophages generating nitric oxide. Biochem J. 284:1992;15-18.
10. Boyhan A., Smith D., Charles I.G., Saqi M., Lowe P.N. Delineation of the arginine- and tetrahydrobiopterin-binding sites of neuronal nitric oxide synthase. Biochem J. 323:1997;131-139.
11. Brenman J.E., Chao D.S., Xia H., Aldape K., Bredt D.S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in duchenne muscular dystrophy. Cell. 82:1995;743-752.
12. 6-(1-iminoethyl)-lysine. Biochemistry. 37:1998;4844-4852.
13. Bryk R., Lubeskie A., Wolff D.J. Studies of nitric oxide synthase inactivation by diverse suicide inhibitors. Arch Biochem Biophys. 369:1999;. in press.
14. Chabin R.M., McCauley E., Calaycay J.R., Kelly T.M., MacNaul K.L., Wolfe G.C., Hutchinson N.I., Madhusudanaraju S., Schmidt J.A., Kozarich J.W., Wong K.K. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole. Biochemistry. 35:1996;9567-9575.
15. Chang W.-J., Iannaccone S.T., Lau K.S., Masters B.S.S., McCabe T.J., McMillan K., Padre R.C., Spencer M.J., Tidball J.G., Stull J.T. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci USA. 93:1996;9142-9147.
16. Chao D.S., Gorospe R.M., Brenman J.E., Rafael J.A., Peters M.F., Froehner S.C., Hoffman E.P., Chamberlain J.S., Bredt D.S. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med. 184:1996;609-618.
17. Cho H.J., Martin E., Xie Q., Sassa S., Nathan C. Inducible nitric oxide synthase. identification of amino acid residues essential for dimerization and binding of tetrahydrobiopterin Proc Natl Acad Sci USA. 92:1995;11514-11518.
18. Christopherson K.S., Bredt D.S. Nitric oxide in excitable tissues. physiological roles and disease J Clin Invest. 100:1997;2424-2429.
19. Clancy R.M., Abramson S.B. Nitric oxide. a novel mediator of inflammation Proc Soc Exp Biol Med. 210:1995;93-101.
20. Cobb J.P., Danner R.L. Nitric oxide and septic shock. JAMA. 275:1996;1192-1196.
21. Connor J.R., Manning P.T., Settle S.L., Moore W.M., Jerome G.M., Webber R.K., Tjoeng F.S., Currie M.G. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol. 273:1995;15-24.
22. Cooper G.R., Barr A., Wolff D.J. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells. Arch Biochem Biophys. 357:1998;195-206.
23. Crane B.R., Arvai A.S., Gachhui R., Wu C., Ghosh D.K., Getzoff E.D., Stuehr D.J., Tainer J.A. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science. 278:1997;425-431.
24. Crane B.R., Arvai A.S., Ghosh D.K., Wu C., Getzoff E.D., Stuehr D.J., Tainer J.A. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science. 279:1998;2121-2126.
25. Crow J.P., Beckman J.S. The role of peroxynitrite in nitric oxide-mediated toxicity. Curr Top Microbiol Immunol. 196:1995;57-73.
26. 4 treatment of rats. Biochem Pharmacol. 34:1985;3203-3206.
27. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate toxicity in primary cortical cultures. Proc Natl Acad Sci USA. 88:1991;6368-6371.
28. Dawson V.L., Kizushi V., Huang M.P.L., Snyder S.H., Dawson T.M. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci. 16:1996;2479-2487.
29. De Matteis F., Hollands C., Gibbs A.H., de Sa N., Rizzardini M. Inactivation of cytochrome P-450 and production of N-alkylated porphyrins caused in isolated hepatocytes by substituted dihydropyridines. Structural requirements for loss of haem and alkylation of the pyrrole nitrogen atom. FEBS Lett. 145:1982;87-92.
30. 3 pituitary cells. J Biol Chem. 257:1982;7566-7573.
31. Dusting G.J., Macdonald P.S. Endogenous nitric oxide in cardiovascular disease and transplantation. Ann Med. 27:1995;395-405.
32. 2+ agonist Bay K 8644 with normal and transformed pituitary cells. Am J Physiol. 250:1986;C95-C102.
33. Evans C.H., Stefanovic-Racic M., Lancaster J. Nitric oxide and its role in orthopaedic disease. Clin Orthop. 312:1995;275-294.
34. Fan B., Wang J., Stuehr D.J., Rousseau D.L. NO synthase isozymes have distinct substrate binding sites. Biochemistry. 36:1997;12660-12665.
35. Fang F.C. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 99:1997;2818-2825.
36. Fostermann U., Gorsky L.D., Pollock J.S., Schmidt H.H.H.W., Heller M., Murad F. Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain. Biochem Biophys Res Commun. 168:1990;727-732.
37. Frey C., Narayanan K., McMillan K., Spack L., Gross S.S., Masters B.S., Griffith O.W. L-Thiocitrulline. J Biol Chem. 269:1994;26083-26091.
38. G-Amino-L-arginine. a new potent antagonist of L-arginine-mediated endothelium-dependent relaxation Biochem Biophys Res Commun. 168:1990;458-465.
39. G-nitroarginine. Biochemistry. 32:1993;8512-8517.
40. Furfine E.S., Harmon M.F., Paith J.E., Knowles R.G., Salter M., Kiff R.J., Duffy C., Hazelwood R., Oplinger J.A., Garvey E.P. Potent and selective inhibition of human nitric oxide synthases. J Biol Chem. 269:1994;26677-26683.
41. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B.J.R., Knowles R.G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem. 272:1997;4959-4963.
42. Gerber N.C., Rodriguez-Crespo I., Nishida C.R., Ortiz de Montellano P.R. Active site topologies and cofactor-mediated conformational changes of nitric-oxide synthases. J Biol Chem. 272:1997;6285-6290.
43. Ghosh D.K., Stuehr D.J. Macrophage NO synthase. characterization of isolated oxygenase and reductase domains reveals a head-to-head subunit interaction Biochemistry. 34:1995;801-807.
44. Ghosh D.K., Abu-Soud H.M., Stuehr D.J. Reconstitution of the second step in NO synthesis using the isolated oxygenase and reductase domains of macrophage NO synthase. Biochemistry. 34:1995;11316-11320.
45. Ghosh D.K., Wu C., Pitters E., Moloney M., Werner E.R., Mayer B., Stuehr D.J. Characterization of the inducible nitric oxide synthase oxygenase domain identifies a 49 amino acid segment required for subunit dimerization and tetrahydrobiopterin interaction. Biochemistry. 36:1997;10609-10619.
46. Giovanelli J., Campos K.L., Kaufman S. Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine. Proc Natl Acad Sci USA. 88:1991;2091-2095.
47. Gonzales-Zulueta M., Ensz L.M., Mukhina G., Lebovitz R.M., Zwacka R.M., Engelhardt J.F., Oberley L.W., Dawson V.L., Dawson T.M. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J Neurosci. 18:1998;2040-2055.
48. Gorren A.C.F., List B.M., Schrammel A., Pitters E., Hemmens B., Werner E.R., Schmidt K., Mayer B. Tetrahydrobiopterin-free neuronal nitric oxide synthase. evidence for two identical highly anticooperative pteridine binding sites Biochemistry. 35:1996;16735-16745.
49. Gorren A.C.F., Schrammel A., Schmidt K., Mayer B. Thiols and neuronal nitric oxide synthase. complex formation, competitive inhibition, and enzyme stabilization Biochemistry. 36:1997;4360-4366.
50. Grant S.K., Green B.G., Stiffey-Wilusz J., Durette P.L., Shah S.K., Kozarich J.W. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors. Biochemistry. 37:1998;4174-4180.
51. Griffith O.W., Stuehr D.J. Nitric oxide synthases. properties and catalytic mechanism Annu Rev Physiol. 57:1995;707-736.
52. G-methylarginine Biochem Biophys Res Commun. 170:1990;96-103.
53. Halpert J. Covalent modification of lysine during the suicide inactivation of rat liver cytochrome P-450 by chloramphenicol. Biochem Pharmacol. 30:1981;875-881.
54. Halpert J., Hammond D., Neal R.A. Inactivation of purified rat liver cytochrome P-450 during the metabolism of parathion (diethyl p-nitrophenyl phosphorothionate). J Biol Chem. 255:1980;1080-1089.
55. Halpert J.R., Guengerich F.P., Bend J.R., Correia M.A. Selective inhibitors of cytochromes P450. Toxicol Appl Pharmacol. 125:1994;163-175.
56. He K., He Y.A., Szklarz G.D., Halpert J.R., Correia M.A. Secobarbital-mediated inactivation of cytochrome P450 2B1 and its active site mutants. Partitioning between heme and protein alkylation and epoxidation. J Biol Chem. 271:1996;25864-25872.
57. Hellermann G.R., Solomonson L.P. Calmodulin promotes dimerization of the oxygenase domain of human endothelial nitric-oxide synthase. J Biol Chem. 272:1997;12030-12034.
58. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 75:1993;1273-1286.
59. Huang P.L., Huang Z., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., Fishman M.C. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:1995;239-242.
60. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
61. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:1997;132-139.
62. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 84:1987;9265-9269.
63. Irikura K., Huang P.L., Ma J., Lee W.S., Dalkara T., Fishman M.C., Dawson T.M., Snyder S.H., Moskowitz M.A. Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression. Proc Natl Acad Sci USA. 92:1995;6823-6827.
64. Johnson M.J., Billiar T.R. Roles of nitric oxide in surgical infection and sepsis. World J Surg. 22:1998;187-196.
65. Kilbourn R.G., Gross S.S., Jubran A., Adams J., Griffith O.W., Levi R., Lodato R.F. N-Methyl-L-arginine inhibits tumor necrosis factor-induced hypotension. implications for the involvment of nitric oxide Proc Natl Acad Sci USA. 87:1990;3629-3632.
66. Klahr S., Morrissey J. Renal disease. two faces of nitric oxide Lab Invest. 72:1995;1-3.
67. Klatt P., Schmidt K., Mayer B. Brain nitric oxide synthase is a hemoprotein. Biochem J. 288:1992;15-17.
68. Klatt P., Schmidt K., Brunner F., Mayer B. Inhibitors of brain nitric oxide synthase. J Biol Chem. 269:1994;1674-1680. a.
69. Klatt P., Schmid M., Leopold E., Schmidt K., Werner E.R., Mayer B. The pteridine binding site of brain nitric oxide synthase. J Biol Chem. 269:1994;13861-13866. b.
70. Klatt P., Schmidt K., Lehner D., Glatter O., Bachinger H.P., Mayer B. Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer. EMBO J. 14:1995;3687-3695.
71. Klatt P., Pfeiffer S., List B.M., Lehner D., Glatter O., Bachinger H.P., Werner E.R., Schmidt K., Mayer B. Characterization of heme-deficient neuronal nitric-oxide synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate and tetrahydrobiopterin. J Biol Chem. 271:1996;7336-7342.
72. Knowles R.G. Keeping the cell reduced. enzymes influencing redox reactions Biochem Soc Trans. 24:1996;875-878.
73. φ-hydroxy-L-arginine to citrulline and nitric oxide. J Biol Chem. 269:1994;17776-17779.
74. Kwon N.S., Nathan C.F., Gilker C., Griffith O.W., Matthews D.E., Stuehr D.J. L-Citrulline production from L-arginine by macrophage nitric oxide synthase. J Biol Chem. 265:1990;13442-13445.
75. 2+ concentrations in the inhibition of mRNA translation. Arch Biochem Biophys. 354:1998;270-280.
76. Lambert L.E., French J.F., Whitten J.P., Baron B.M., McDonald I.A. Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis. Eur J Pharmacol. 216:1992;131-134.
77. Lee S.-J., Stull J.T. Calmodulin-dependent regulation of inducible and neuronal nitric-oxide synthase. J Biol Chem. 273:1998;27430-27437.
78. Liaudet L., Rosselet A., Schaller M.-D., Markert M., Perret C., Feihl F. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis. 177:1998;127-132.
79. List B.M., Klosch B., Volker C., Gorren A.C.F., Sessa W.C., Werner E.R., Kukovetz W.R., Schmidt K., Mayer B. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity. tetrahydrobiopterin binding kinetics and role of haem in dimerization Biochem J. 323:1997;159-165.
80. Loscalzo J., Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 38:1995;87-104.
81. Lowe P.N., Smith D., Stammers D.K., Riveros-Moreno V., Moncada S., Charles I., Boyhan A. Identification of the domains of neuronal nitric oxide synthase by limited proteolysis. Biochem J. 314:1996;55-62.
82. Lowenstein C.J., Glatt C.S., Bredt D.S., Snyder S.H. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA. 89:1992;6711-6715.
83. MacMicking J.D., North R.J., LaCourse R., Mudgett J.S., Shah S.K., Nathan C.F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA. 94:1997;5243-5248. a.
84. MacMicking J., Xie Q., Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 15:1997;323-350. b.
85. Mansuy D., Boucher J.L., Clement B. On the mechanism of nitric oxide formation upon oxidative cleavage of C=N(OH) bonds by NO-synthases and cytochromes P450. Biochimie. 77:1995;661-667.
86. Marletta M.A. Nitric oxide synthase structure and mechanism. J Biol Chem. 268:1993;12231-12234.
87. Marletta M.A. Nitric oxide synthase. aspects concerning structure and catalysis Cell. 78:1994;927-930.
88. Masters B.S.S., McMillan K., Sheta E.A., Nishimura J.S., Roman L.J., Martasek P. Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution. structure studies of a cysteine thiolate-liganded heme protein that hydroxylates L-arginine to produce NO• as a cellular signal FASEB J. 10:1996;552-558.
89. Mayer B., Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci. 22:1997;477-481.
90. Mayer B., Wu C., Gorren A.C.F., Pfeiffer S., Schmidt K., Clark P., Stuehr D.J., Werner E.R. Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase. heme spin shift and dimer stabilization by the potent pterin antagonist 1-amino-tetrahydrobiopterin Biochemistry. 36:1997;8422-8427.
91. McCall T.B., Feelisch M., Palmer R.M.J., Moncada S. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br J Pharmacol. 102:1991;234-238.
92. McCartney-Francis N., Allen J.B., Mizel D.E., Albina J.E., Xie Q., Nathan C.F., Wahl S.M. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med. 178:1993;749-754.
93. Michel T., Feron O. Nitric oxide synthases. which, where, how, and why? J Clin Invest. 100:1997;2146-2152.
94. Moilanen E., Vapaatalo H. Nitric oxide in inflammation and immune response. Ann Med. 27:1995;359-367.
95. Moncada S., Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9:1995;1319-1330.
96. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide. physiology, pathophysiology, and pharmacology Pharmacol Rev. 43:1991;109-141.
97. Moore P.K., Handy R.L.C. Selective inhibitors of neuronal nitric oxide synthase - is no NOS really good NOS for the nervous system? Trends Pharmacol Sci. 18:1997;204-211.
98. 6-(1-iminoethyl)lysine. a selective inhibitor of inducible nitric oxide synthase J Med Chem. 37:1994;3886-3888.
99. Narayanan K., Spack L., McMillan K., Kilbourn R.G., Hayward M.A., Masters B.S.S., Griffith O. S-Alkyl-L-thiocitrullines. J Biol Chem. 270:1995;11103-11110.
100. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
101. Nathan C. Inducible nitric oxide synthase. what difference does it make? J Clin Invest. 100:1997;2417-2423.
102. Nathan C., Xie Q. Nitric oxide synthases. roles, tolls, and controls Cell. 78:1994;915-918.
103. Nava E., Noll G., Luscher T.F. Nitric oxide in cardiovascular diseases. Ann Med. 27:1995;343-351.
104. Ogden J.E., Moore P.K. Inhibition of nitric oxide synthase - potential for a novel class of therapeutic agent? Trends Biotechnol. 13:1995;70-78.
105. G-cyclopropyl-L-arginine. two novel inhibitors of macrophage nitric oxide synthase J Med Chem. 35:1992;1137-1144.
106. Olken N.M., Marletta M.A. N-Methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry. 32:1993;9677-9685.
107. G-methyl-L-arginine. evidence for heme loss Biochemistry. 33:1994;14784-14791.
108. Ortiz de Montellano P.R. Free radical modification of prosthetic heme groups. Pharmacol Ther. 48:1990;95-120.
109. Ortiz de Montellano P.R. Mechanism-based inactivation of cytochrome P-450. isolation and characterization of N-alkyl heme adducts Methods Enzymol. 206:1991;533-540.
110. Ortiz de Montellano P.R., Correia M.A. Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annu Rev Pharmacol Toxicol. 23:1983;481-503.
111. Ortiz de Montellano P.R., Komives E.A. Branchpoint for heme alkylation and metabolite formation in the oxidation of arylacetylenes by cytochrome P-450. J Biol Chem. 260:1985;3330-3336.
112. Ortiz de Montellano, P. R., & Reich, N. O. (1986). Dissociation of increased lauric acid omega-hydroxylase activity from the antilipidemic action of clofibrate. In P. R. Ortiz de Montellano (Ed.), Cytochrome P-450: Structure, Mechanism, and Biochemistry (pp. 273-314). New York: Plenum Press.
113. Osawa Y., Pohl L.R. Covalent bonding of the prosthetic heme to protein. a potential mechanism for the suicide inactivation or activation of hemoproteins Chem Res Toxicol. 2:1989;131-141.
114. Oyama J.-I., Shimokawa H., Momii H., Cheng X.-S., Fukuyama N., Arai Y., Egashira K., Nakazawa H., Takeshita A. Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Clin Invest. 101:1998;2207-2214.
115. Paakkari I., Lindsberg P. Nitric oxide in the central nervous system. Ann Med. 27:1995;369-377.
116. G-nitro-L-arginine Br J Pharmacol. 118:1996;1433-1440.
117. Pfeiffer S., Gorren A.C.F., Pitters E., Schmidt K., Werner E.R., Mayer B. Allosteric modulation of rat brain nitric oxide synthase by the pterin-site enzyme inhibitor 4-aminotetrahydrobiopterin. Biochem J. 328:1997;349-352.
118. Presta A., Siddhanta U., Wu C., Sennequier N., Huang L., Abu-Soud H.M., Erzurum S., Stuehr D.J. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry. 37:1998;298-310.
119. Radomski M.W., Palmer R.M.J., Moncada S. Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol. 101:1990;325-328.
120. Rapoport R.M., Murad F. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle. role of cyclic GMP J Cyclic Nucleotide Protein Phosphorylation Res. 9:1983;281-290.
121. Rees D.D., Palmer R.M.J., Schulz R., Hodson H.F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 101:1990;746-752.
122. Reif D.W., McCreedy S.A. N-Nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases. Arch Biochem Biophys. 320:1995;170-176.
123. Rodrigues-Crespo I., Gerber N.C., Ortiz de Montellano P.R. Endothelial nitric-oxide synthase. J Biol Chem. 271:1996;11462-11467.
124. 2+. J Biol Chem. 271:1996;22679-22686.
125. Sakai N., Kaufman S., Milstien S. Tetrahydrobiopterin is required for cytokine-induced nitric oxide production in a murine macrophage cell line (RAW 264). Mol Pharmacol. 43:1992;6-10.
126. Salerno J.C., Frey C., McMillan K., Williams R.F., Masters B.S.S., Griffith O.W. Characterization by electron paramagnetic resonance of the interactions of L-arginine and L- thiocitrulline with the heme cofactor region of nitric oxide synthase. J Biol Chem. 270:1995;27423-27428.
127. Salerno J.C., Harris D.E., Irizarry K., Patel B., Morales A.J., Smith S.M.E., Martasek P., Roman L.J., Masters B.S., Jones C.L., Weissman B.A., Lane P., Liu Q., Gross S.S. An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J Biol Chem. 272:1997;29769-29777.
128. Schoedon G., Schneemann M., Hofer S., Guerrero L., Blau N., Schaffner A. Regulation of the L-arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages. Eur J Biochem. 213:1993;833-839.
129. Schulz R., Triggle C.R. Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol Sci. 15:1994;255-259.
130. Sennequier N., Stuehr D.J. Analysis of substrate-induced electronic, catalytic, and structural changes in inducible NO synthase. Biochemistry. 35:1996;5883-5892.
131. Shaul P.W., Smart E.J., Robinson L.J., German Z., Yuhanna I.S., Ying Y., Anderson R.G.W., Michel T. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem. 271:1996;6518-6522.
132. Shesely E.G., Maeda N., Kim H.-S., Desai K.M., Krege J.H., Laubach V.E., Sherman P.A., Sessa W.C., Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 93:1996;13176-13181.
133. Sheta E.A., McMillan K., Masters B.S. Evidence for a bidomain structure of constitutive cerebellar nitric oxide synthase. J Biol Chem. 269:1994;15147-15153.
134. Siddhanta U., Wu C., Abu-Soud H.M., Zhang J., Ghosh D.K., Stuehr D.J. Heme iron reduction and catalysis by a nitric oxide synthase heterodimer containing one reductase and two oxygenase domains. J Biol Chem. 271:1996;7309-7312.
135. Siddhanta U., Presta A., Fan B., Wolan D., Rousseau D.L., Stuehr D.J. Domain swapping in inducible nitric-oxide synthase. J Biol Chem. 273:1998;18950-18958.
136. Silverman R.B. Mechanism-Based Enzyme Inactivation: Chemistry and Enzymology, Vol. 1. 1988;CRC Press, Boca Raton.
137. Son H., Hawkins R.D., Martin K., Kiebler M., Huang P.L., Fishman M.C., Kandel E.R. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell. 87:1996;1015-1023.
138. Southan G.J., Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol. 51:1996;383-394.
139. Stefanovic-Racic M., Meyers K., Meschter C., Coffey J.W., Hoffman R.A., Evans C.H. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol. 22:1995;1922-1928.
140. G-monomethyl-arginine in vitro and in vivo. Eur J Pharmacol. 294:1995;703-712.
141. Stevens J.C., Jaw J.-Y., Peng C.-T., Halpert J. Mechanism-based inactivation of bovine adrenal cytochromes P450 C-21 and P450 17 alpha by 17 beta-substituted steroids. Biochemistry. 30:1991;3649-3658.
142. Stevens-Truss R., Marletta M.A. Interaction of calmodulin with the inducible murine macrophage nitric oxide synthase. Biochemistry. 34:1995;15638-15645.
143. Stuehr D.J. Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol. 37:1997;339-359.
144. Stuehr D.J., Griffith O.W. Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol. 65:1992;287-346.
145. Stuehr D.J., Ikeda-Saito M. Spectral characterization of brain and macrophage nitric oxide synthases. J Biol Chem. 267:1992;20547-20550.
146. φ-Hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem. 266:1991;6259-6263.
147. Su Z., Blazing M.A., Fan D., George S.E. The calmodulin-nitric oxide synthase interaction. J Biol Chem. 270:1995;29117-29122.
148. Tikkanen I., Fyhrquist F. Nitric oxide in hypertension and renal disease. Ann Med. 27:1995;353-357.
149. Tzeng E., Billiar T.R. Nitric oxide and the surgical patient. Arch Surg. 132:1997;977-982.
150. Vaupel D.B., Kimes A.S., London E.D. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology. 13:1995;315-322.
151. Venema R.C., Sayegh H.S., Kent J.D., Harrison D.G. Identification, characterization, and composition of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases. J Biol Chem. 271:1996;6435-6440.
152. Venema R.C., Ju H., Zou R., Ryan J.W., Venema V.J. Subunit interactions of endothelial nitric-oxide synthase. J Biol Chem. 272:1997;1276-1282.
153. Walsh C.T. Suicide substrates, mechanism-based enzyme inactivators. recent developments Annu Rev Biochem. 53:1984;493-535.
154. Wang J., Stuehr D.J., Ikeda-Saito M., Rousseau D.L. Heme coordination and structure of the catalytic site in nitric oxide synthase. J Biol Chem. 268:1993;22255-22258.
155. Wang J., Stuehr D.J., Rousseau D.L. Tetrahydrobiopterin-deficient nitric oxide synthase has a modified heme environment and forms a cytochrome P-420 analogue. Biochemistry. 34:1995;7080-7087.
156. Watanabe Y., Hu Y., Hidaka H. Identification of a specific amino acid cluster in the calmodulin-binding domain of the neuronal nitric oxide synthase. FEBS Lett. 403:1997;75-78.
157. Weiner C., Lizasoain I., Baylis S.A., Knowles R.G., Charles I.G., Moncada S. Induction of calcium-dependent nitric oxide synthase by sex hormones. Proc Natl Acad Sci USA. 91:1994;5212-5216.
158. Werner E.R., Pitters E., Schmidt K., Wachter H., Werner-Felmayer G., Mayer B. Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase. Biochem J. 320:1996;193-196.
159. White K.A., Marletta M.A. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry. 31:1996;6627-6631.
160. Wilson R.I., Yanovsky J., Godecke A., Stevens D.R., Schrader J., Haas H.L. Endothelial nitric oxide and LTP. Nature. 386:1997;338.
161. Wolff D.J., Lubeskie A. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch Biochem Biophys. 316:1995;290-301.
162. G-amino-L-arginine. Arch Biochem Biophys. 325:1996;227-234.
163. Wolff D.J., Datto G.A., Samatovicz R.A., Tempsick R.A. Calmodulin-dependent nitric oxide synthase. J Biol Chem. 268:1993;9425-9429.
164. Wolff D.J., Gauld D., Neulander M.J., Southan G. Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas. J Pharmacol Exp Ther. 283:1997;265-273. a.
165. Wolff D.J., Lubeskie A., Li C. Inactivation and recovery of nitric oxide synthetic capability in cytokine-induced RAW 264.7 cells treated with "irreversible" NO synthetic inhibitors. Arch Biochem Biophys. 338:1997;73-82. b.
166. 5-iminoethyl-L-ornithine. Eur J Pharmacol. 350:1998;325-334.
167. Wu G., Morris S.M. Arginine metabolism. nitric oxide and beyond Biochem J. 336:1998;1-17.
168. Xia Y., Dawson V.L., Dawson T.M., Snyder S.H., Zweier J.L. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA. 93:1996;6770-6774.
169. Xie Q., Leung M., Fuortes M., Sassa S., Nathan C. Complementation analysis of mutants of nitric oxide synthase reveals that the active site requires two hemes. Proc Natl Acad Sci USA. 93:1996;4891-4896.
170. φ-allyl-L-arginine. J Am Chem Soc. 119:1997;10888-10902. a.
171. φ-propyl-L-arginine. J Med Chem. 40:1997;3869-3870. b.
172. Zhao W., Tilton R.G., Corbett J.A., McDaniel M.L., Misko T.P., Williamson J.R., Cross A.H., Hickey W.F. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol. 64:1996;123-133.